US2022211921A1PendingUtilityA1

Surgical system and methods of use

Assignee: MEDTRONIC INCPriority: Jan 6, 2021Filed: Jan 6, 2021Published: Jul 7, 2022
Est. expiryJan 6, 2041(~14.4 yrs left)· nominal 20-yr term from priority
A61N 1/37512A61N 1/375A61K 31/195A61B 2017/00336A61L 2300/21A61N 1/057A61L 31/141A61L 2300/406A61N 1/3956A61N 1/059A61L 2300/204A61L 2300/216A61B 2017/00893A61L 27/34A61K 31/65A61L 27/54A61K 31/496A61L 31/16A61L 2300/418A61L 31/10A61L 31/146A61L 2400/04A61L 2300/252
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A surgical system including an implantable medical device having a size and shape. The surgical device having a substrate and a coating that covers at least a portion of the substrate. The coating including collagen, glycerin and a hemostatic agent. The substrate including a first piece and a second piece that is joined with the first piece. The first piece and the second piece forming a pocket having a cavity and an opening that is in communication with the cavity. The device being pre-formed such that a size and shape of the cavity conforms to the size and shape of the implantable medical device.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A surgical system comprising:
 an implantable medical device having a size and shape;   a surgical device comprising a substrate and a coating that covers at least a portion of the substrate, the coating comprising collagen, glycerin and a hemostatic agent, the substrate comprising a first piece and a second piece that is joined with the first piece, the first piece and the second piece forming a pocket having a cavity and an opening that is in communication with the cavity, the device being pre-formed such that a size and shape of the cavity conforms to the size and shape of the implantable medical device.   
     
     
         2 . The surgical system recited in  claim 1 , wherein the implantable medical device is configured to be inserted through the opening and into the cavity. 
     
     
         3 . The surgical system recited in  claim 1 , wherein the implantable medical device is a pacemaker. 
     
     
         4 . The surgical system recited in  claim 1 , wherein the implantable medical device is a cardioverter-defibrillator. 
     
     
         5 . The surgical system recited in  claim 1 , wherein the implantable medical device is positioned in the cavity. 
     
     
         6 . The surgical system recited in  claim 5 , wherein the implantable medical device is a pacemaker. 
     
     
         7 . The surgical system recited in  claim 5 , wherein the implantable medical device is a cardioverter-defibrillator. 
     
     
         8 . The surgical system recited in  claim 1 , wherein the hemostatic agent is trans-4-(aminomethyl)cyclohexanecarboxylic acid (C 8 H 15 NO 2 ). 
     
     
         9 . The surgical system recited in  claim 1 , wherein the coating consists of collagen, glycerin and the hemostatic agent. 
     
     
         10 . The surgical system recited in  claim 1 , wherein the collagen is CPP collagen. 
     
     
         11 . The surgical system recited in  claim 1 , wherein the collagen is CPX collagen. 
     
     
         12 . The surgical system recited in  claim 1 , wherein the coating is free of ECM collagen. 
     
     
         13 . The surgical system recited in  claim 1 , further comprising a package, the package including an aperture and an insert positioned within the aperture, the insert being configured to be positioned in the cavity to maintain the size and shape of the cavity. 
     
     
         14 . The surgical system recited in  claim 1 , further comprising a package, the package including an aperture and an insert positioned within the aperture, the insert being positioned in the cavity to maintain the size and shape of the cavity. 
     
     
         15 . A surgical system comprising:
 a package, the package including an aperture and an insert positioned within the aperture;   an implantable medical device having a size and shape, wherein the implantable medical device is a pacemaker or a cardioverter-defibrillator;   a surgical device comprising a substrate and a coating that covers at least a portion of the substrate, the coating comprising collagen, glycerin and a hemostatic agent, the collagen including CPP collagen or CPX collagen, the substrate comprising a first piece and a second piece that is joined with the first piece, the first piece and the second piece forming a pocket having a cavity and an opening that is in communication with the cavity, the device being pre-formed such that a size and shape of the cavity conforms to the size and shape of the implantable medical device, the insert being positioned in the cavity to maintain the size and shape of the cavity.   
     
     
         16 . The surgical system recited in  claim 15 , wherein the hemostatic agent is trans-4-(aminomethyl)cyclohexanecarboxylic acid (C 8 H 15 NO 2 ). 
     
     
         17 . The surgical system recited in  claim 16 , wherein the coating consists of collagen, glycerin and the hemostatic agent. 
     
     
         18 . A surgical system comprising:
 a package, the package including an aperture and an insert positioned within the aperture;   an implantable medical device having a size and shape, wherein the implantable medical device is a pacemaker or a cardioverter-defibrillator;   a surgical device comprising a substrate and a coating that covers at least a portion of the substrate, the coating comprising collagen, glycerin and a hemostatic agent, the collagen including CPP collagen or CPX collagen, the substrate comprising a first piece and a second piece that is joined with the first piece, the first piece and the second piece forming a pocket having a cavity and an opening that is in communication with the cavity, the device being pre-formed such that a size and shape of the cavity conforms to the size and shape of the implantable medical device, the implantable medical device being positioned in the cavity, the insert being configured to be positioned in the cavity to maintain the size and shape of the cavity.   
     
     
         19 . The surgical system recited in  claim 18 , wherein the hemostatic agent is trans-4-(aminomethyl)cyclohexanecarboxylic acid (C 8 H 15 NO 2 ). 
     
     
         20 . The surgical system recited in  claim 19 , wherein the coating consists of collagen, glycerin and the hemostatic agent.

Join the waitlist — get patent alerts

Track US2022211921A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.